Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Janet Vaughn

VP North America Generics Regulatory Affairs
Teva Pharmaceuticals

I bring my more than two decades of experience – from the lab to regulatory affairs – to guide strategic decision making to ensure smooth, expedient approvals and quality submissions with the FDA and other relevant regulatory agencies.​ As Vice President of Regulatory Affairs at Teva Pharmaceuticals Ltd., I work across Teva functions to provide input on all functions in service of generic drug approvals, including R&D formulation development, clinical activities, and quality assurance. I am driven to help Teva navigate evolving regulatory guides to be able to push the boundaries of science and deliver innovation to patients.

Disclosure information not submitted.

Presentation(s):